TY - JOUR
T1 - Fertility preservation during the COVID-19 pandemic
T2 - mitigating the viral contamination risk to reproductive cells in cryostorage
AU - Adiga, Satish K.
AU - Tholeti, Prathima
AU - Uppangala, Shubhashree
AU - Kalthur, Guruprasad
AU - Gualtieri, Roberto
AU - Talevi, Riccardo
N1 - Publisher Copyright:
© 2020 Reproductive Healthcare Ltd.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Reopening fertility care services across the world in the midst of a pandemic brings with it numerous concerns that need immediate addressing, such as the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the male and female reproductive cells and the plausible risk of cross-contamination and transmission. Due to the novelty of the disease the literature contains few reports confirming an association of SARS-CoV-2 with reproductive tissues, gametes and embryos. Cryobanking, an essential service in fertility preservation, carries the risk of cross-contamination through cryogenic medium and thus calls for risk-mitigation strategies. This review aims to address the available literature on the presence of SARS-CoV-2 on tissues, gametes and embryos, with special reference to the possible sources of cross-contamination through liquid nitrogen. Strategies for risk mitigation have been extrapolated from reports dealing with other viruses to the current global crisis, for safety in fertility treatment services in general, and specifically for oncofertility.
AB - Reopening fertility care services across the world in the midst of a pandemic brings with it numerous concerns that need immediate addressing, such as the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the male and female reproductive cells and the plausible risk of cross-contamination and transmission. Due to the novelty of the disease the literature contains few reports confirming an association of SARS-CoV-2 with reproductive tissues, gametes and embryos. Cryobanking, an essential service in fertility preservation, carries the risk of cross-contamination through cryogenic medium and thus calls for risk-mitigation strategies. This review aims to address the available literature on the presence of SARS-CoV-2 on tissues, gametes and embryos, with special reference to the possible sources of cross-contamination through liquid nitrogen. Strategies for risk mitigation have been extrapolated from reports dealing with other viruses to the current global crisis, for safety in fertility treatment services in general, and specifically for oncofertility.
UR - http://www.scopus.com/inward/record.url?scp=85092081427&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092081427&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2020.09.013
DO - 10.1016/j.rbmo.2020.09.013
M3 - Review article
AN - SCOPUS:85092081427
SN - 1472-6483
VL - 41
SP - 991
EP - 997
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 6
ER -